SAN FRANCISCO, Jan. 31, 2011 /PRNewswire/ -- ClinOps is a specialized contract research organization with a core service offering combining expert data management, biostatistics and specialized clinical services. Emphusion targets development programs in biotechnology, medical device, and pharmaceutical industries when these services are a key to success. The company will change its name to Emphusion effective immediately.
"Through acquisition and internal initiatives, we have grown our business in three core areas; data management, biostatistics and clinical services. Through past investment and a recent infusion of additional capital our primary investor, DW Healthcare Partners, continues to support our company strategy and new brand direction. Both our investors and our leadership believe it is important to have a company name reflecting our full portfolio of services and our direction for the future," said David Herron, CEO & President of ClinOps. "By creating a recognizable brand, we will emphasize our strength in bringing three key, distinctive services to our clients assisting them in exceeding their goals."
"The name Emphusion, which is derived from emphasis and fusion, was selected based upon extensive research with customers and industry experts," continued Mr. Herron. "The history of this company is centered around the ideas, experiences and execution of our employees. The fusion of these components is what our continued success will be built upon. The new name is appropriate for a company that sees its primary task as playing a critical role in assisting to bring emerging companies and products to the global healthcare marketplace."
About EmphusionEmphusion integrates ideas, experience and execution to assist clients in accelerating decisions. Emphusion's core service offering combines expert data management, distinctive biostatistics and specialized clinical services. Emphusion targets development progr